Introduction: The eighth edition of the American Joint Committee on Cancer (AJCC)
melanoma staging system was implemented in the United States on 1 January 2018. Areas …

Simple Summary Researchers have shown that tumor biomarkers and increased nerve
density are important clinical tools for determining cancer prognosis and developing …

Abstract Background Vulvar melanoma (VuM) and vaginal melanoma (VaM) represent a
unique subgroup of malignant melanomas with important differences in biology and …

Ten percent of all women have pigmented vulvar lesions. Fortunately, most of these are
benign but 1% of all melanomas in women affect the vulva. While the mortality rate of …

Vulvar malignant melanoma (VMM) is a rare disease, accounting for 5% of all vulvar
malignancies and is characterized by low survival and high recurrence rates. It is considered …

Objective The objective of this study is to determine the association of proliferation indices
and pathologic biomarkers on overall and recurrence/metastasis‐free survival (OS and …

Objective immunotherapy with immune checkpoint inhibitors has become one of the
standard therapeutic modalities for patients with advanced melanoma. Melanoma of the …

Pathological staging of primary anorectal mucosal melanoma is often performed according
to the American Joint Commission on Cancer (AJCC) guidelines for cutaneous melanoma …

The incidence of melanoma in the United States has been increasing over the past several
decades. Prognosis largely depends on disease stage, with 5-year melanoma-specific …

Genitourinary (GU) melanoma is a rare presentation of melanoma accounting for
approximately 0.5% of all melanomas. GU melanomas include primary melanomas of the …